Evidence map›Paper›PMID 41039759›Full record

ArticleThe American journal of case reports2025

Necrotizing Fasciitis and Targeted Muscle Reinnervation in the Upper Extremity: A Case Report.

Joaquín Herrera Leigh, Carlos A Córdova, Sara Fischer

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joaquín Herrera LeighDepartment of Traumatology and Orthopaedic, Hospital del Trabajador, Santiago, Chile.ORCID 0009-0008-4900-2257
Carlos A CórdovaDepartment of Traumatology and Orthopaedic, Hospital del Trabajador, Santiago, Chile.
Sara FischerDepartment of Traumatology and Orthopaedic, Hospital del Trabajador, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Necrotizing fasciitis is a rare but increasingly prevalent, rapidly progressive soft tissue infection with high morbidity and mortality. While cases of lower limb involvement are more frequent, cases affecting the upper limb, especially leading to proximal major amputations, such as transhumeral amputation, are exceedingly rare. Targeted muscle reinnervation (TMR) is an innovative approach, aimed at improving postoperative outcomes and pain control. We report a case with sudden clinical presentation that was managed initially with emergency amputation. Postoperative neuroma-related pain was treated using TMR. CASE REPORT A 48-year-old man with untreated psoriasis sustained a right wrist crush injury. Initially discharged with mild contusion, he returned 48 h later with severe swelling, pain, and systemic symptoms. Imaging and laboratory test results indicated NF. Despite broad-spectrum antibiotics and ICU support, he developed septic shock and multi-organ failure. Six hours later, emergency transhumeral amputation was performed, with hemodynamic stabilization. After 2 additional debridements, he improved and was discharged. At 6 months, he had neuroma-related pain. TMR was performed, resolving the symptoms. He was in rehabilitation, awaiting prosthesis fitting and training, at the time of this report. CONCLUSIONS Upper limb NF is an uncommon but life-threatening condition requiring prompt diagnosis and aggressive treatment. The Laboratory Risk Indicator for Necrotizing Fasciitis score is a useful diagnostic tool, and early surgical intervention remains the cornerstone of therapy. When amputation is necessary, postoperative complications, including chronic and phantom limb pain, can occur. TMR is a promising surgical approach for reducing pain and improving function in upper limb amputees.

Indexed as

Fasciitis, NecrotizingMuscle, SkeletalUpper ExtremityAmputation, SurgicalDebridementHumansMaleMiddle Aged

Identifiers

PMID41039759
PMCPMC12502989

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.